Reminder of an Investor Conference Webinar
We would like to remind that KN invites shareholders, investors, analysts, and other stakeholders to join its investor conference webinar scheduled on November 28th of 2022 at 9.00 am (EET). The presentation will be held in English.
The webinar will be hosted by KN Chief Executive Officer Darius Šilenskis and Chief Financial Officer Mindaugas Kvekšas who will introduce the performance and unaudited financial results of KN for the nine months of 2022.
How to join the webinar?
To join the webinar, please register via following link:
https://nasdaq.zoom.us/webinar/register/WN_TP7ex_xbTf-DIVw4OeZLIgYou will be provided with the webinar link and instructions how to join successfully. When joining the webinar for the first time, you will be asked to register on the Zoom platform. The webinar will be recorded and available online for everyone at the company’s website on www.kn.lt/en/and on Nasdaq Baltic youtube.com account.
What is a corporate webinar?
A corporate webinar is a virtual conference, during which company’s representatives provide information about the company and its performance. Webinar allows interactive communication and a possibility to ask questions and get answers directly from the company while being located anywhere.
Mindaugas Kvekšas, Chief Financial Officer, +370 46 391772
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Amlan International Adds Sales Manager, Distribution Partner and is Granted New Registration of Calibrin-Z in the Philippines29.11.2022 22:41:20 CET | Press release
CHICAGO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Amlan International, the animal health business of Oil-Dri® Corporation of America, is pleased to announce exciting new developments for their business in the Philippines. Jayson Fernandez joined Amlan as a sales manager for the Philippines in January 2022 and FJ Wegon Animal Health and Nutrition Inc. is now registered to distribute proven biotoxin binder Calibrin®-Z. Registration is pending of additional high-value feed additives, such as patented Varium®, designed for poultry feed efficiency. The Philippines is the fourth-largest poultry producer in Southeast Asia, producing 1.4 million tons of broiler meat in 2020, and the third-largest swine producer in Asia, producing 1.5 million tons of pork meat. However, these production achievements have not been without challenges. The poultry industry is still recovering from COVID-19 disruptions, and swine repopulation efforts are continuing after African swine fever outbreaks. “As producers in the
Kvalitena AB (publ) publicerar kvartalsrapport för Q3 202229.11.2022 22:00:00 CET | Pressemelding
Kvalitena publicerar kvartalsrapport för Q3 2022 Bilaga Delårsrapport Q3 2022
Conagen develops high-purity non-GMO sulforaphane by bioconversion29.11.2022 21:23:38 CET | Press release
Commercial production is underway for 2023. Bedford, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Expanding on its portfolio of innovative nutritional products through biotechnology, Conagen, announced the development of its 99% high-purity sulforaphane. Made by a proprietary bioconversion technology, the company plans to begin the commercialization path in 2023. Conagen’s bioconversion methods enable the production of sustainable products from many naturally occurring compounds regardless of rarity or small quantities occurring in nature. “As a supplement product, Conagen’s high-purity sulforaphane is appealing to consumers as the levels found in raw vegetables are too low to realize many of its promising health benefits,” said Casey Lippmeier, Ph.D., senior vice president of innovation. “We’re looking forward to expanding the nutritional market by commercializing sulforaphane in 2023.” Sulforaphane has been associated with supporting health benefits against cancer, diabetes, digestion, a
Yara’s employee share purchase program and mandatory notification of trades29.11.2022 19:02:00 CET | Press release
Oslo, 29 November 2022: The Foundation for employees’ shares in Yara (“Stiftelsen For Ansattes Aksjer i Yara”) has today purchased a total of 34,000 Yara shares (ticker: YAR, ISIN: NO0010208051) in the market at an average price of NOK 463.9398 per share, as part of Yara’s employee share purchase program in Norway. Permanent Yara employees in Norway can take part in the annual offer to buy Yara shares for a value of either NOK 7,500, NOK 15,000 or NOK 30,000. Based on the three alternatives, Yara employees purchased either 16 Yara shares, 32 Yara shares or 64 Yara shares at NOK 466.40 per share. In total, Yara employees purchased 33,264 Yara shares from the Foundation for employees’ shares in Yara. A total of 605 employees participated in the program. Following these transactions, the Foundation for employees’ shares in Yara owns 748 Yara shares. The share purchases linked to the employee share purchase program by the following Yara Board members are considered as PDMR trades under the
Rovio Entertainment Corporation: Repurchase of own shares on 29 November 202229.11.2022 17:45:00 CET | Press release
Rovio Entertainment Oyj STOCK EXCHANGE RELEASE 29.11.2022 at 18.45 EETRovio Entertainment Corporation - Repurchase of own shares on 29.11.2022Rovio Entertainment CorporationIn the Nasdaq HelsinkiDate29.11.2022Exchange transactionBUYShare trading codeROVIOAmount, shares27148Average price/share, EUR5,942434Total cost, EUR161325,20Rovio now holds a total of 6 382 613 shares including the shares repurchased on 29.11.2022On behalf of Rovio Entertainment CorporationOP Corporate Bank PLC Further information: Timo Rahkonen, VP Investor Relations & Corporate Strategy +358 40 730 3442 RovioIR@rovio.com Distribution: Nasdaq Helsinki Ltd Key media www.rovio.com About Rovio: Rovio Entertainment Corporation is a global mobile-first games company that creates, develops and publishes mobile games, which have been downloaded over 5 billion times. Rovio is best known for the global Angry Birds brand, which started as a popular mobile game in 2009, and has since evolved from games to various entertainmen